March 23, 2020
Abuse Complaint from the U.S. Food and Drug Administration - Office of Criminal Investigations
14455 N. Hayden Rd., Suite 219
Scottsdale, AZ 85260
VIA EMAIL: email@example.com
The United States Food and Drug Administration is a consumer protection agency that is, among other things, responsible for regulating the safety of medical products in the United States. After our review, it appears that the websites listed below is offering to distribute in interstate commerce to United States consumers medical products that are intended to treat, prevent, cure, or mitigate COVID-19 infection in violation of the Federal Food, Drug, and Cosmetic Act found at Title 21, United States Code, Section 301 et seq. (the “FDCA”). Violations of the FDCA are subject to enforcement action, including but not limited to seizure, injunction, and criminal prosecution. See 21 U.S.C. §§ 332-334.
The domain names listed below is registered by your company and are currently accessible to consumers in the United States.
This is an abuse complaint submitted to you under Section 3.18.2 of the 2013 ICANN Registrar Accreditation Agreement regarding the use of domain names for illegal purposes. The 2013 RAA contains requirements pertaining to your duty to investigate and respond appropriately to reports of illegal activity (Sections 3.18 and 1.13). We are respectfully requesting your company review these sites for violations of your terms of service or acceptable use policy.
Thank you for your prompt attention to this matter. If you have any questions, I can be reached at (b)(6).
Cybercrime Investigations Unit